Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India.

摘要: In clinical practice, every year approximately 150,000 children are referred with short stature (SS) based on a cut-off of fifth percentile. The most important endocrine and treatable cause SS is growth hormone deficiency (GHD). lack reliable data the prevalence GHD in India limits estimation magnitude this problem. diagnosis treatment hurdled various challenges, restricting availability (GH) therapy to only very limited segment India. This review will firstly summarize gaps challenges literature analysis. Subsequently, it presents suggestions from members at advisory board meetings overcome these challenges. suggested that early initiation could better chances achieving final adult height within normal range for population. Education awareness about disorders among parents, regular training physicians, more emphasis using Indian charts monitoring would help improve GHD. Availability an easy-to-use delivery system also be beneficial improving adherence satisfactory outcomes.